{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:25:55Z","timestamp":1792304755924,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ygyno.2012.08.028","type":"journal-article","created":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T18:32:15Z","timestamp":1346265135000},"page":"595-600","source":"Crossref","is-referenced-by-count":10,"title":["Detection of PAX8 and p53 is beneficial in recognizing metastatic carcinomas in pelvic washings, especially in cases with suspicious cytology"],"prefix":"10.1016","volume":"127","author":[{"given":"Li","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.08.028_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0010","first-page":"95","article-title":"Accuracy of immunohistochemistry in evaluation of malignant pleural and peritoneal effusions","volume":"62","author":"Ensani","year":"2011","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0015","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/dvdy.21711","article-title":"Perplexing Pax: from puzzle to paradigm","volume":"237","author":"Blake","year":"2008","journal-title":"Dev Dyn"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0020","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","article-title":"Tubal origin of low-grade serous carcinoma","volume":"24","author":"Li","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0030","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","article-title":"Live or let die: the cell's response to p53","volume":"2","author":"Vousden","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0045","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1158\/1078-0432.CCR-07-4837","article-title":"Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma","volume":"14","author":"Jia","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.pgp.0000235065.31301.3e","article-title":"Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma","volume":"26","author":"Chiesa-Vottero","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1438.2007.01039.x","article-title":"Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance","volume":"18","author":"Salani","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cncy.20089","article-title":"Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology","volume":"118","author":"McKnight","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0070","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/cncr.22919","article-title":"Metastatic patterns at autopsy in patients with ovarian carcinoma","volume":"110","author":"Guth","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/GRF.0b013e318218c6d1","article-title":"Recurrent Endometrial Cancer","volume":"54","author":"del Carmen","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0080","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/1097-0142(19830915)52:6<1026::AID-CNCR2820520617>3.0.CO;2-3","article-title":"Adenocarcinoma of the endometrium analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons","volume":"52","author":"Eifel","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000478-199206000-00008","article-title":"Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features","volume":"16","author":"Sherman","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0090","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e318202772e","article-title":"A proposed model for endometrial serous carcinogenesis","volume":"35","author":"Zheng","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0095","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1432-1033.1995.tb20338.x","article-title":"Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors","volume":"228","author":"Poleev","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/cncy.20136","article-title":"PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens","volume":"119","author":"Haynes","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/jclinpath-2011-200508","article-title":"PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody","volume":"65","author":"Hu","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study","volume":"19","author":"Tacha","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mce.2009.10.013","article-title":"The role of the PAX8\/PPAR [gamma] fusion oncogene in the pathogenesis of follicular thyroid cancer","volume":"321","author":"Eberhardt","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0120","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0125","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PGP.0b013e31821ac6c3","article-title":"Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53","volume":"30","author":"Brunner","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/dc.21426","article-title":"Pax8: a marker for carcinoma of M\u00fcllerian origin in serous effusions","volume":"39","author":"Tong","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2559.2007.02938.x","article-title":"Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective","volume":"53","author":"Jarboe","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"3","author":"Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ygyno.2012.08.028_bb0155","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.2353\/ajpath.2009.081085","article-title":"Molecular identification of \u201cLatent precancers\u201d for endometrial serous carcinoma in benign-appearing endometrium","volume":"174","author":"Zhang","year":"2009","journal-title":"Am J Pathol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812007214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812007214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:54:29Z","timestamp":1594601669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812007214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0090825812007214"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.08.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}